ARCHIVES

FDA Proposes New Nonclinical Lab Regs

This article is from The Cancer Letter archive.

Vol. 02 No. 48 | November 26, 1976

Download PDF Visit The Full Archive

Related Articles

Report Urges Better Working Conditions For Postdocs.

October 6, 2000

ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial.

September 8, 2006

Smoking & Health Contractors Meet

July 11, 1975

Controversy Raging On Whether To Release Data On 5-FU/Levamisole, Stop Untreated Control Arm

June 9, 1989

Annual Report Key Element In Prevention Drive, Maquire Insists

February 2, 1979

ACS Board Approves Special Donors Concept, Oks New Program or Cause And Prevention Research

February 23, 1979